Risk of metastatic disease using [¹⁸F]PSMA-1007 PET/CT for primary prostate cancer staging.

ABSTRACT:

Background

Accurate prostate cancer imaging is critical for patient management. Multiple studies have demonstrated superior diagnostic accuracy of [⁶⁸Ga]-PSMA-11 PET/CT over conventional imaging for disease detection, with validated clinical and biochemical predictors of disease detection. More recently [¹⁸F]PSMA-1007 offers theoretical imaging advantages, but there is limited evidence of clinical and biochemical predictors of scan findings in the staging population. This study investigates the association of clinical variables with imaging characteristics among patients who underwent [¹⁸F]PSMA-1007 PET/CT for primary staging of men with histopathologically confirmed prostate carcinoma. A retrospective review of 194 consecutive patients imaged betwe

SUBMITTER: Chikatamarla VA 

PROVIDER: S-EPMC8688644 | biostudies-literature | 2021 Dec

REPOSITORIES: biostudies-literature